×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
BNGO – bionano genomics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
BNGO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/27
08:00 am
bngo
Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale
Low
Report
Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale
2/26
08:34 am
bngo
10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM's Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders [Yahoo! Finance]
Low
Report
10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM's Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders [Yahoo! Finance]
2/26
08:00 am
bngo
10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders
Low
Report
10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders
2/25
08:00 am
bngo
11 Presentations on Day 2 of Bionano Symposium 2026 Showcase Expanding Impact of Optical Genome Mapping Across Oncology and Cell & Gene Therapy
Low
Report
11 Presentations on Day 2 of Bionano Symposium 2026 Showcase Expanding Impact of Optical Genome Mapping Across Oncology and Cell & Gene Therapy
2/24
08:00 am
bngo
9 Presentations Kick Off Day 1 of the Bionano Symposium 2026 Covering Advances in Optical Genome Mapping for Hematologic Malignancies
Low
Report
9 Presentations Kick Off Day 1 of the Bionano Symposium 2026 Covering Advances in Optical Genome Mapping for Hematologic Malignancies
2/9
09:05 am
bngo
Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping
Neutral
Report
Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping
2/4
08:00 am
bngo
Bionano Announces Publication from Sanford Burnham Prebys Medical Discovery Institute Describing use of OGM to Detect Genomic Alterations Introduced by Gene Editing Technologies
Medium
Report
Bionano Announces Publication from Sanford Burnham Prebys Medical Discovery Institute Describing use of OGM to Detect Genomic Alterations Introduced by Gene Editing Technologies
1/12
08:00 am
bngo
Bionano Reports Preliminary Fourth Quarter and Full-Year 2025 Results
Low
Report
Bionano Reports Preliminary Fourth Quarter and Full-Year 2025 Results
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/18
04:32 pm
bngo
Form 4 Bionano Genomics, Inc. For: Feb 17 Filed by: Chaubey Alka
Low
Report
Form 4 Bionano Genomics, Inc. For: Feb 17 Filed by: Chaubey Alka
2/18
04:28 pm
bngo
Form 4 Bionano Genomics, Inc. For: Feb 17 Filed by: Dixon Jonathan V.
Low
Report
Form 4 Bionano Genomics, Inc. For: Feb 17 Filed by: Dixon Jonathan V.
2/18
04:27 pm
bngo
Form 4 Bionano Genomics, Inc. For: Feb 17 Filed by: OLDAKOWSKI MARK
Low
Report
Form 4 Bionano Genomics, Inc. For: Feb 17 Filed by: OLDAKOWSKI MARK
2/18
04:26 pm
bngo
Form 4 Bionano Genomics, Inc. For: Feb 17 Filed by: Holmlin R. Erik
Low
Report
Form 4 Bionano Genomics, Inc. For: Feb 17 Filed by: Holmlin R. Erik
2/17
04:07 pm
bngo
Form SCHEDULE 13G/A Bionano Genomics, Inc. Filed by: Lind Global Fund III LP
Medium
Report
Form SCHEDULE 13G/A Bionano Genomics, Inc. Filed by: Lind Global Fund III LP
2/17
02:47 pm
bngo
Form SCHEDULE 13G/A Bionano Genomics, Inc. Filed by: CVI Investments, Inc.
Low
Report
Form SCHEDULE 13G/A Bionano Genomics, Inc. Filed by: CVI Investments, Inc.
2/4
04:20 pm
bngo
Form 4 Bionano Genomics, Inc. For: Feb 02 Filed by: Adamchak Mark
Medium
Report
Form 4 Bionano Genomics, Inc. For: Feb 02 Filed by: Adamchak Mark
2/4
04:18 pm
bngo
Form 4 Bionano Genomics, Inc. For: Feb 02 Filed by: Chaubey Alka
Medium
Report
Form 4 Bionano Genomics, Inc. For: Feb 02 Filed by: Chaubey Alka
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
10/16
Top Researchers to Present Discoveries Made Possible by Bionano’s Saphyr System for Genome Imaging Technology at the ASHG 2019 Annual Meeting
417.6%
2/28 Bionano Genomics to Report Fourth Quarter and Year End 2019 Financial Results and Host a Conference Call and Webcast on March 5 25.0%
11/12 Takeaways from AMP 2019 in Baltimore: Users of Bionano’s Saphyr System Presented Results from Multiple Studies Demonstrating the System’s Utility for a Variety of Disease Indications 24.7%
10/21 Form S-1MEF Bionano Genomics, Inc 20.0%
11/6 Novogene Adopts Bionano’s Saphyr System Adding Saphyr’s Ultra-Sensitive and Ultra-Specific Structural Variation Detection to their Repertoire of Services 14.6%
4/24 BioNano Genomics Inc (NASDAQ: BNGO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 12.7%
6/13 Leading Scientists and Clinicians Are Presenting Results From a Record Number of Studies at ESHG 2019 Showing How the Saphyr System From Bionano Genomics Provides Critical Insights Into Cancer and Genetic Disease and is Leading the Way to Digital Cytogene 9.1%
10/22 Form EFFECT Bionano Genomics, Inc 7.4%
3/6 Form 4 Bionano Genomics, Inc For: Mar 01 Filed by: Robinson Warren 7.0%
2/20 Form 4 Bionano Genomics, Inc For: Feb 18 Filed by: Adams Heather 6.7%
2/28 Bionano Genomics to Report Fourth Quarter and Year End 2019 Financial Results and Host a Conference Call and Webcast on March 5 25.0%
11/12 Takeaways from AMP 2019 in Baltimore: Users of Bionano’s Saphyr System Presented Results from Multiple Studies Demonstrating the System’s Utility for a Variety of Disease Indications 24.7%
10/21 Form S-1MEF Bionano Genomics, Inc 20.0%
11/6 Novogene Adopts Bionano’s Saphyr System Adding Saphyr’s Ultra-Sensitive and Ultra-Specific Structural Variation Detection to their Repertoire of Services 14.6%
4/24 BioNano Genomics Inc (NASDAQ: BNGO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 12.7%
6/13 Leading Scientists and Clinicians Are Presenting Results From a Record Number of Studies at ESHG 2019 Showing How the Saphyr System From Bionano Genomics Provides Critical Insights Into Cancer and Genetic Disease and is Leading the Way to Digital Cytogene 9.1%
10/22 Form EFFECT Bionano Genomics, Inc 7.4%
3/6 Form 4 Bionano Genomics, Inc For: Mar 01 Filed by: Robinson Warren 7.0%
2/20 Form 4 Bionano Genomics, Inc For: Feb 18 Filed by: Adams Heather 6.7%
TOP News Decliners
10/18
Form SC 13G/A Bionano Genomics, Inc Filed by: HIRSCHMAN ORIN
-49.5%
4/1 Form S-1MEF Bionano Genomics, Inc -37.4%
3/5 Bionano Genomics Reports Fourth Quarter and Year End 2019 Financial Results and Provides Business Update -32.9%
3/10 Bionano Genomics Will Be Used in Research Identifying Gene Variants that Contribute to Coronavirus Disease Susceptibility -30.9%
10/17 Bionano Genomics down 23% on equity offering [Seeking Alpha] -30.7%
3/31 Bionano Genomics to Support Largest Study to Date on COVID-19 Disease Susceptibility -29.3%
3/10 Form 10-K Bionano Genomics, Inc For: Dec 31 -27.0%
9/18 Form S-1 Bionano Genomics, Inc -20.1%
10/23 Form 424B4 Bionano Genomics, Inc -14.1%
11/7 Form 8-K Bionano Genomics, Inc For: Nov 07 -13.7%
4/1 Form S-1MEF Bionano Genomics, Inc -37.4%
3/5 Bionano Genomics Reports Fourth Quarter and Year End 2019 Financial Results and Provides Business Update -32.9%
3/10 Bionano Genomics Will Be Used in Research Identifying Gene Variants that Contribute to Coronavirus Disease Susceptibility -30.9%
10/17 Bionano Genomics down 23% on equity offering [Seeking Alpha] -30.7%
3/31 Bionano Genomics to Support Largest Study to Date on COVID-19 Disease Susceptibility -29.3%
3/10 Form 10-K Bionano Genomics, Inc For: Dec 31 -27.0%
9/18 Form S-1 Bionano Genomics, Inc -20.1%
10/23 Form 424B4 Bionano Genomics, Inc -14.1%
11/7 Form 8-K Bionano Genomics, Inc For: Nov 07 -13.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: